A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency
暂无分享,去创建一个
Liesbet Lagae | Jarne Pauwels | Francis Impens | Kris Gevaert | Frances M. Platt | Jesse Trekker | Wim Annaert | L. Lagae | W. Annaert | Jarne Pauwels | K. Gevaert | R. Sannerud | J. Swinnen | A. Tharkeshwar | J. Trekker | Wendy Vermeire | D. Priestman | Danielle Te Vruchte | K. Vints | P. Baatsen | J. Decuypere | Huiqi Lu | Shaun Martin | P. Vangheluwe | F. Impens | F. Platt | Shaun Martin | Pieter Baatsen | Johannes V. Swinnen | Peter Vangheluwe | Arun Kumar Tharkeshwar | Wendy Vermeire | Ragna Sannerud | David A. Priestman | Danielle te Vruchte | Katlijn Vints | Jean-Paul Decuypere | Huiqi Lu | Ragna Sannerud | Katlijn Vints | Francis Impens
[1] M. Kilner,et al. Studies of the double surfactant layer stabilization of water-based magnetic fluids , 1991 .
[2] T. Steck,et al. Characterization of lysosomes isolated from Dictyostelium discoideum by magnetic fractionation. , 1993, The Journal of biological chemistry.
[3] P. Greengard,et al. Alzheimer Amyloid Protein Precursor Is Localized in Nerve Terminal Preparations to Rab5-containing Vesicular Organelles Distinct from Those Implicated in the Synaptic Vesicle Pathway* , 1996, The Journal of Biological Chemistry.
[4] Frederick E. Petry,et al. Principles and Applications , 1997 .
[5] G. Griffiths,et al. Localization of five annexins in J774 macrophages and on isolated phagosomes. , 1997, Journal of cell science.
[6] K. Mills,et al. Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders , 1998, FEBS letters.
[7] R. Brady,et al. Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] T. A. Hatton,et al. Bilayer Surfactant Stabilized Magnetic Fluids: Synthesis and Interactions at Interfaces , 1999 .
[9] Y. Ioannou,et al. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. , 1999, Molecular genetics and metabolism.
[10] M. Patterson,et al. The Niemann-Pick C1 Protein Resides in a Vesicular Compartment Linked to Retrograde Transport of Multiple Lysosomal Cargo* , 1999, The Journal of Biological Chemistry.
[11] Sabino Veintemillas-Verdaguer,et al. Surface and Internal Spin Canting in γ-Fe2O3 Nanoparticles , 1999 .
[12] Y. Ioannou. The structure and function of the Niemann-Pick C1 protein. , 2000, Molecular genetics and metabolism.
[13] R. Wattiaux,et al. Identification of HE1 as the second gene of Niemann-Pick C disease. , 2000, Science.
[14] L. Liscum. Niemann–Pick Type C Mutations Cause Lipid Traffic Jam , 2000, Traffic.
[15] S. Loening,et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia , 2001 .
[16] Hao Zeng,et al. Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.
[17] Vincent Noireaux,et al. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.
[18] J. Bacri,et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. , 2003, Biomaterials.
[19] Steven W. Taylor,et al. Global organellar proteomics. , 2003, Trends in biotechnology.
[20] M. Mann,et al. Proteomic characterization of the human centrosome by protein correlation profiling , 2003, Nature.
[21] R. Costo,et al. The preparation of magnetic nanoparticles for applications in biomedicine , 2003 .
[22] M. Shen,et al. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] Megha,et al. Ceramide Selectively Displaces Cholesterol from Ordered Lipid Domains (Rafts) , 2004, Journal of Biological Chemistry.
[24] R. Dwek,et al. Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport* , 2004, Journal of Biological Chemistry.
[25] M. Mann,et al. The abc's (and xyz's) of peptide sequencing , 2004, Nature Reviews Molecular Cell Biology.
[26] Rod B. Watson,et al. Localization of Organelle Proteins by Isotope Tagging (LOPIT)*S , 2004, Molecular & Cellular Proteomics.
[27] T. A. Hatton,et al. Structure of polymer-stabilized magnetic fluids: small-angle neutron scattering and mean-field lattice modeling. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[28] R. Dwek,et al. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. , 2004, Analytical biochemistry.
[29] N. O’Rourke,et al. Protein localization studies in the age of 'Omics'. , 2005, Current opinion in chemical biology.
[30] J. Slotte,et al. Displacement of sterols from sterol/sphingomyelin domains in fluid bilayer membranes by competing molecules. , 2005, Biochimica et biophysica acta.
[31] T. A. Hatton,et al. Controlled clustering and enhanced stability of polymer-coated magnetic nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[32] J. Yates,et al. Proteomics of organelles and large cellular structures , 2005, Nature Reviews Molecular Cell Biology.
[33] Gerald C. Chu,et al. XBP‐1 is required for biogenesis of cellular secretory machinery of exocrine glands , 2005, The EMBO journal.
[34] Hiroyuki Honda,et al. Medical application of functionalized magnetic nanoparticles. , 2005, Journal of bioscience and bioengineering.
[35] D. Leslie-Pelecky,et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. , 2005, Molecular pharmaceutics.
[36] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[37] R. Gordon,et al. NPC1 late endosomes contain elevated levels of non-esterified ('free') fatty acids and an abnormally glycosylated form of the NPC2 protein. , 2005, The Biochemical journal.
[38] Giorgio Valle,et al. Quantitative Proteomic Comparison of Rat Mitochondria from Muscle, Heart, and Liver *S , 2006, Molecular & Cellular Proteomics.
[39] Christophe Danelon,et al. Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells. , 2006, Angewandte Chemie.
[40] Helmut Grubmüller,et al. Molecular Anatomy of a Trafficking Organelle , 2006, Cell.
[41] M. Mann,et al. Organellar proteomics: turning inventories into insights , 2006, EMBO reports.
[42] F. Cordelières,et al. A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.
[43] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[44] G. Stucky,et al. Self-assembled virus-like particles with magnetic cores. , 2007, Nano letters.
[45] Marco Lattuada,et al. Functionalization of monodisperse magnetic nanoparticles. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[46] Jinwoo Cheon,et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.
[47] Laura Beretta,et al. Proteomics from the clinical perspective: many hopes and much debate , 2007, Nature Methods.
[48] A. Galione,et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium , 2008, Nature Medicine.
[49] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[50] S. Souchelnytskyi,et al. Proteomic approaches in biological and medical sciences: principles and applications. , 2008, Experimental oncology.
[51] C. Serna,et al. Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. , 2009, The journal of physical chemistry. B.
[52] R. Aebersold,et al. Evolution of organelle-associated protein profiling. , 2009, Journal of proteomics.
[53] P. Saftig,et al. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function , 2009, Nature Reviews Molecular Cell Biology.
[54] R A Knight,et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.
[55] Sabino Veintemillas-Verdaguer,et al. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells , 2009, Nanotechnology.
[56] Stefan R Bornstein,et al. A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language , 2011, Genome Biology.
[57] Eoin Fahy,et al. Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.
[58] J. Z. Hilt,et al. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. , 2010, Nanomedicine.
[59] Z. Elazar,et al. LC3 and GATE‐16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis , 2010, The EMBO journal.
[60] Juan Antonio Vizcaíno,et al. Organelle proteomics experimental designs and analysis , 2010, Proteomics.
[61] Joseph L. Goldstein,et al. Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. , 2010, Cell metabolism.
[62] J. Ellenberg,et al. The quantitative proteome of a human cell line , 2011, Molecular systems biology.
[63] B. de Strooper,et al. ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1 , 2011, Proceedings of the National Academy of Sciences.
[64] A. Ballabio,et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. , 2011, Human molecular genetics.
[65] Martin Kircher,et al. Deep proteome and transcriptome mapping of a human cancer cell line , 2011, Molecular systems biology.
[66] Wolfgang Link,et al. Protein localization in disease and therapy , 2011, Journal of Cell Science.
[67] K. Chapman,et al. Organellar lipidomics , 2011, Plant signaling & behavior.
[68] Kai Simons,et al. Membrane lipidome of an epithelial cell line , 2011, Proceedings of the National Academy of Sciences.
[69] F. Platt,et al. Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. , 2011, Cell calcium.
[70] Gustaaf Borghs,et al. A novel strategy for the comprehensive analysis of the biomolecular composition of isolated plasma membranes , 2011, Molecular systems biology.
[71] J. Searcy,et al. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[72] Xian-Ping Dong,et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release , 2012, Nature Communications.
[73] E. Knecht,et al. Annexin A5 stimulates autophagy and inhibits endocytosis , 2012, Journal of Cell Science.
[74] S. Murphy,et al. Lipidomics applications in health, disease and nutrition research. , 2013, Molecular nutrition & food research.
[75] M. A. Surma,et al. Organellar lipidomics--background and perspectives. , 2013, Current opinion in cell biology.
[76] R. Jaenisch,et al. Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease. , 2013, Cell reports.
[77] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[78] P. Saftig,et al. Lysosomal Membrane Proteins and Their Central Role in Physiology , 2013, Traffic.
[79] J. Vance,et al. Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin , 2014, Journal of Lipid Research.
[80] B. Brügger,et al. Lipidomics: analysis of the lipid composition of cells and subcellular organelles by electrospray ionization mass spectrometry. , 2014, Annual review of biochemistry.
[81] M. Orešič,et al. Systems biology strategies to study lipidomes in health and disease. , 2014, Progress in lipid research.
[82] A. Ballabio,et al. Lysosomal adaptation: how the lysosome responds to external cues. , 2014, Cold Spring Harbor perspectives in biology.
[83] J. Goldstein,et al. Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection , 2015, eLife.
[84] Zhenwen Zhao,et al. The Lipidomic Analyses in Low and Highly Aggressive Ovarian Cancer Cell Lines , 2016, Lipids.
[85] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticle for in vivo molecular and cellular imaging , 2014 .
[86] N. Vaziri,et al. Lipidomics: new insight into kidney disease. , 2015, Advances in clinical chemistry.
[87] N. He,et al. Applications of Magnetic Nanoparticles in Targeted Drug Delivery System. , 2015, Journal of nanoscience and nanotechnology.
[88] J. Yates,et al. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann–Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis* , 2015, Molecular & Cellular Proteomics.
[89] G. Ramm,et al. Atg8 family LC3/GABARAP proteins are crucial for autophagosome–lysosome fusion but not autophagosome formation during PINK1/Parkin mitophagy and starvation , 2016, The Journal of cell biology.
[90] Sangeeta Khare,et al. Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .
[91] A. Rofe,et al. Purification of Lysosomes Using Supraparamagnetic Iron Oxide Nanoparticles (SPIONs). , 2016, Cold Spring Harbor protocols.
[92] Warren C. W. Chan,et al. DNA-controlled dynamic colloidal nanoparticle systems for mediating cellular interaction , 2016, Science.
[93] Daniel Horák,et al. Size-dependent magnetic properties of iron oxide nanoparticles , 2016 .
[94] Organelle , 2019, Definitions.